Portrait of Welch, Peter

Welch, Peter

U.S. Representative VT Democratic Party

Congressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.

Disclosed trades
117
Buys / sells
34% / 66%
Last trade
Nov 26, 2021
Last filing
Aug 13, 2022

Latest disclosed trades

Latest 10 of 117
Ticker Type Traded
UNP Sell Nov 26, 2021
IBM Sell Nov 26, 2021
GE Sell Nov 26, 2021
SwedenCare Ab [OT] F ILINg S TAT Sell Nov 19, 2021
UN Sell Nov 18, 2021
KUBTY Sell Nov 18, 2021
A Sell Nov 18, 2021
TNC Sell Nov 18, 2021
ADSK Sell Nov 18, 2021
MITK Sell Nov 18, 2021

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.

Welch, Peter stock trade activity

FilingIQ has indexed 117 congressional stock trade disclosures for Welch, Peter. The most recent disclosed transaction is dated Nov 26, 2021.

Across the full history, 40 purchases and 77 sales have been disclosed under the STOCK Act.

Top tickers traded by Welch, Peter

Frequently asked

How many stock trades has Welch, Peter disclosed?
FilingIQ tracks 117 Periodic Transaction Report disclosures for Welch, Peter, with the most recent dated Nov 26, 2021. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Welch, Peter a net buyer or net seller?
Across the disclosed trade history, 40 (34%) were purchases and 77 (66%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Welch, Peter come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.